Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling.
about
Shiga toxin 2 targets the murine renal collecting duct epitheliumPodocytesEndothelin Blockade in Diabetic Kidney DiseaseEndothelin and the glomerulus in chronic kidney diseaseEndothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the ratNatural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice.p38 mitogen-activated protein kinase mediates lipopolysaccharide and tumor necrosis factor alpha induction of shiga toxin 2 sensitivity in human umbilical vein endothelial cellsInteractions of Shiga-like toxin with human peripheral blood monocytes.Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice.Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.Shiga toxin pathogenesis: kidney complications and renal failure.Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complementDirect acute tubular damage contributes to Shigatoxin-mediated kidney failure.Chronic endothelin-1 infusion elevates glomerular sieving coefficient and proximal tubular albumin reuptake in the ratEndothelin and endothelin antagonists in chronic kidney disease.Endothelin and the podocyteRegulation of blood pressure and salt homeostasis by endothelin.ET-1 actions in the kidney: evidence for sex differences.Endothelin-1 and the kidney--beyond BP.Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism.Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetesβ-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury.Physiology of endothelin and the kidney.Protection of human podocytes from shiga toxin 2-induced phosphorylation of mitogen-activated protein kinases and apoptosis by human serum amyloid P componentDirect action of endothelin-1 on podocytes promotes diabetic glomerulosclerosisNuclear membrane receptors for ET-1 in cardiovascular function.Podocyte dysfunction in aging--related glomerulosclerosis.Endothelin antagonism for patients with chronic kidney disease: still a hope for the future.Endothelin Receptor Antagonists: New Hope for Renal Protection?Role of the endothelin system in sexual dimorphism in cardiovascular and renal diseases.Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells.Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes.Hyperoside alleviates adriamycin-induced podocyte injury via inhibiting mitochondrial fission.Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.ABIN1 Determines Severity of Glomerulonephritis via Activation of Intrinsic Glomerular Inflammation.Long-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice.
P2860
Q24652310-92DDBA07-E871-4BA7-81A5-ABD6CBAA473AQ26766118-BAD2FA69-6014-46CE-8F92-6332ACAE1C8EQ26799476-BBA5BC8E-24A6-4519-8616-5BEFF9A0E0EBQ26828634-DF93AF74-AFA7-4F22-A713-2D26E5716817Q28575856-05154BE0-48D5-42A3-92CE-830820BAF37AQ30300135-C0D0EFE1-AC69-46B9-BBC1-A017B36BE1C4Q30441434-1191AD47-EFC5-4CBF-8F89-D82683538F00Q33375578-D391985A-871D-4197-8542-BC6B196EF8B6Q33382197-087DC27A-B0D6-4FAB-BC37-A7138AE4124EQ33394010-D4F58A42-D9D7-4022-A411-2B96F9B87582Q33397541-3F500CBB-27C1-49B9-A793-D71CB7338C3BQ33413591-A3B38C5D-4FDD-4C49-9142-0DB7693F40E5Q33415795-7A2E579E-1ED0-4FBF-9CFE-30626E1B29A2Q34315591-277773E7-D54A-496E-8837-D4B972C45213Q34437692-FCDA6FA4-04BB-4C33-B02D-BB1A6FDA0D55Q35452282-2FC51B57-747E-4DE1-BA17-5235200161FBQ35609851-456D92C4-CD23-4C63-A416-9EB6AE800DEEQ36610325-F3124917-E029-4054-8064-1C438E367669Q36619734-D02804A8-418C-4BEF-B8EF-605AF88F0EC9Q36788592-B32ABD4F-739D-4418-B9C1-B3BB90827A28Q37244688-470198B8-45BE-4461-B424-811FF88F11D1Q37604733-AF4ACFCE-01CA-44F3-A61E-95C7423E5217Q37613679-CFFFD2AB-77D5-4804-BF31-CEE1FD184816Q37713382-742CC088-05D7-47B1-969B-0B7C83A1D4A1Q37733555-2F9EF4A1-012B-42B6-B735-D015A28E1879Q37810395-F4250B22-359F-48E6-A5A4-A57EC989C37FQ37881701-14AD3281-BD52-4ACD-A78C-71A11061C2BFQ38185016-D994924D-FF7E-4387-8695-33C601C2968DQ38525983-F21C4C37-25C6-4EC0-922C-2D0330C4A71CQ38759324-0352B5B0-3367-4FF2-A7EE-59AF1888A6A3Q40011026-02F61393-EFFB-42AF-9F39-50C4CA94F7B5Q43292843-DEE483A2-964F-4730-BE7E-7337A17C4A8DQ47148010-433FA12B-BB5E-4066-A972-A956B680B19AQ47321222-DB9D1C5D-B880-4AAF-A119-B44F9EF66E17Q47765187-B263C437-50EE-4638-9E67-1ABB871FCEE2Q50667811-C35B8003-5A0A-45E3-84CC-2805B25B4F56
P2860
Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Shigatoxin-induced endothelin- ...... lly mediates actin remodeling.
@en
type
label
Shigatoxin-induced endothelin- ...... lly mediates actin remodeling.
@en
prefLabel
Shigatoxin-induced endothelin- ...... lly mediates actin remodeling.
@en
P2093
P2860
P1476
Shigatoxin-induced endothelin- ...... lly mediates actin remodeling.
@en
P2093
Carla Zoja
Cristina Zanchi
Daniela Macconi
Daniela Moioli
Lorena Longaretti
Marina Morigi
Simona Buelli
P2860
P304
P356
10.2353/AJPATH.2006.051331
P407
P577
2006-12-01T00:00:00Z